Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancer
Citrin, D.L.; Tormey, D.C.; Carbone, P.P.
Cancer Treatment Reports 61(7): 1249-1252
1977
ISSN/ISBN: 0361-5960 PMID: 589595 Document Number: 119890
The 99mTc diphosphonate scan is important in the study of primary breast cancer. The short-term prognosis for scan-positive patients is poor. Serial bone scans provide a safe and reliable prognostic index in patients following mastectomy. By correlating the scan with biochemical tumor markers, a matrix of diagnostic tests may be developed that is capable of identifying high-risk patients who may benefit from systemic therapy.